These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12577460)

  • 1. [Gastropathies caused by non-steroidal antirheumatic agents].
    Dítĕ P; Novotný I
    Vnitr Lek; 2002 Nov; 48(11):1075-81. PubMed ID: 12577460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of prostaglandins in the pathogenesis of stomach ulcer and gastropathy caused by non-steroid anti-inflammatory drugs].
    Lazebnik LB; Tkachenko VN; Kolomiets EV
    Eksp Klin Gastroenterol; 2005; (1):4-7, 106. PubMed ID: 15991845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment and prophylaxis of alimentary tract lesions caused by non-steroid anti-inflammatory drugs].
    Gil J; Wojtuń S
    Pol Merkur Lekarski; 2009 May; 26(155):353-7. PubMed ID: 19606672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec.
    Moride Y; Ducruet T; Rochon S; Lavoie F
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii17-22. PubMed ID: 14585914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
    Vakhrushev IaM; Loshchakova OIu
    Eksp Klin Gastroenterol; 2007; (1):60-3, 71. PubMed ID: 17547116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions.
    Tomisato W; Tsutsumi S; Hoshino T; Hwang HJ; Mio M; Tsuchiya T; Mizushima T
    Biochem Pharmacol; 2004 Feb; 67(3):575-85. PubMed ID: 15037209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
    Fialová P; Vlcek J
    Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage.
    Lim YJ; Lee JS; Ku YS; Hahm KB
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1169-78. PubMed ID: 19682191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A
    Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-steroidal anti-inflammatory drugs and intestinal side effects].
    Stadnicki A; Frysz-Naglak D
    Wiad Lek; 2007; 60(5-6):286-90. PubMed ID: 17966896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroscopic findings after therapy with non-steroid antirheumatic drugs.
    Tympner F
    Z Rheumatol; 1981; 40(4):179-81. PubMed ID: 7293523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
    Vakil N
    Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective cyclooxygenase-2 inhibitors and the digestive tract].
    Chaabouni H; Amouri A; Cheikh I; Kchaou M; Ouerghi H; Ben Mami N; Ben Ammar A
    Tunis Med; 2002 Aug; 80(8):427-33. PubMed ID: 12703120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to define in diagnosis endoscopically detected lesions of gastrointestinal mucosa which arose in th time of administration of nonsteroidal antiinflammatory drugs?].
    Murav'ev IuV
    Klin Med (Mosk); 2000; 78(11):61-3. PubMed ID: 11232536
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nonsteroidal antirheumatic agents and the gastrointestinal system].
    Jajić I
    Reumatizam; 1990; 37(1-6):3-9. PubMed ID: 2135454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.